Barbara J Sahakian Selected Research

dopamine beta hydroxylase deficiency

1/2022

Locus coeruleus integrity correlates with inhibitory functions of the fronto-subthalamic 'hyperdirect' pathway in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara J Sahakian Research Topics

Disease

26	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 01/2003
14	Schizophrenia (Dementia Praecox) 01/2022 - 07/2004
11	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2003
10	Cognitive Dysfunction 10/2023 - 08/2003
9	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2002
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 05/2012
4	Substance-Related Disorders (Drug Abuse) 11/2023 - 11/2005
4	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 03/2011
4	Autism Spectrum Disorder 01/2022 - 01/2020
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2018
4	Gambling (Pathological Gambling) 01/2022 - 07/2004
4	Huntington Disease (Huntington's Disease) 01/2020 - 05/2003
3	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 11/2013
3	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 05/2006
3	Disease Progression 01/2018 - 12/2010
3	Depressive Disorder (Melancholia) 12/2015 - 01/2004
2	Dementia (Dementias) 07/2022 - 01/2018
2	Autistic Disorder (Autism) 01/2022 - 01/2020
2	Mental Disorders (Mental Disorder) 12/2021 - 10/2017
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 12/2015
2	Alcoholism (Alcohol Abuse) 01/2019 - 01/2018
2	Neurobehavioral Manifestations 10/2017 - 04/2015
2	Fatigue 03/2017 - 11/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2013 - 11/2008
2	Mood Disorders (Mood Disorder) 01/2012 - 08/2007
2	Trichotillomania 12/2010 - 12/2006
1	Tobacco Use Disorder (Nicotine Dependence) 01/2023
1	Neoplasms (Cancer) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	dopamine beta hydroxylase deficiency 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Consciousness Disorders 01/2021
1	Stroke (Strokes) 01/2021
1	Weight Gain 10/2020
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017
1	Anxiety Disorders (Anxiety Disorder) 01/2017
1	Social Phobia 10/2014
1	Atrophy 06/2013
1	Meningoencephalitis 04/2013

Drug/Important Bio-Agent (IBA)

19	Methylphenidate (Ritalin)FDA LinkGeneric 01/2024 - 08/2003
13	Modafinil (Provigil)FDA Link 03/2017 - 01/2003
11	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2003
9	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2016 - 07/2007
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2011
7	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 04/2005
5	Serotonin (5 Hydroxytryptamine)IBA 12/2021 - 04/2005
4	Bumetanide (Bumex)FDA LinkGeneric 01/2022 - 01/2020
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 03/2011
4	Amphetamine (Amfetamine)FDA LinkGeneric 09/2007 - 05/2004
3	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 01/2020
3	Nootropic Agents (Nootropics)IBA 10/2017 - 07/2004
2	Indicators and Reagents (Reagents)IBA 01/2023 - 07/2022
2	Capsules (Microcapsules)IBA 01/2022 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 02/2020 - 01/2020
2	Naltrexone (ReVia)FDA LinkGeneric 01/2019 - 01/2018
2	Citalopram FDA LinkGeneric 03/2016 - 04/2014
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2015 - 04/2015
2	Wakefulness-Promoting AgentsIBA 03/2012 - 03/2011
2	Tryptophan (L-Tryptophan)FDA Link 01/2012 - 07/2004
2	CatecholaminesIBA 06/2011 - 02/2004
2	Serotonin and Noradrenaline Reuptake InhibitorsIBA 04/2009 - 11/2007
2	Tyrosine (L-Tyrosine)FDA Link 04/2005 - 01/2004
1	Cocaine (Cocaine HCl)IBA 11/2023
1	Escitalopram FDA Link 10/2023
1	Opioid Receptors (Opioid Receptor)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 07/2022
1	CytokinesIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	InterferonsIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 12/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Muscarinic M1 ReceptorIBA 01/2020
1	Biperiden (Akineton)FDA Link 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2017
1	Insulin (Novolin)FDA Link 03/2017
1	N 30IBA 03/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Serotonin AgentsIBA 03/2016
1	GlucocorticoidsIBA 12/2015
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2014
1	Therapeutic UsesIBA 11/2013
1	AutoreceptorsIBA 11/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 05/2004
4	Cognitive Training 01/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
3	Behavior Control 10/2020 - 12/2007
1	Transcranial Direct Current Stimulation 12/2021
1	Precision Medicine 12/2021
1	Neurological Rehabilitation 01/2021
1	Deep Brain Stimulation 01/2019
1	Secondary Prevention 01/2018
1	Ambulatory Care (Outpatient Care) 01/2017
1	Transplantation 06/2013
1	Cell Transplantation 06/2013